{
  "disease_name": "Niemann-Pick disease type C",
  "orpha_code": "646",
  "drugs": [
    {
      "name": "MIGLUSTAT GEN. ORPH",
      "substance_url": null,
      "substance_id": null,
      "regulatory_url": "/en/drug/regulatory/645014?name=646&mode=orpha&region=",
      "regulatory_id": "645014",
      "orpha_substance_code": "ORPHA:646",
      "details": [
        "MIGLUSTAT GEN. ORPH(Tradename                        - 29/04/2019)Disease(s) concernedORPHA:646 Niemann-Pick disease type C",
        "MIGLUSTAT GEN. ORPH(Tradename                        - 29/04/2019)",
        "(Tradename                        - 29/04/2019)",
        "Disease(s) concernedORPHA:646 Niemann-Pick disease type C",
        "More details on the regulatory status"
      ],
      "links": [
        {
          "url": "https://www.orpha.net/en/drug/trade_name/501216?name=646&mode=orpha&region=&status=all",
          "text": "MIGLUSTAT GEN. ORPH",
          "type": "trade_name_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/646",
          "text": "ORPHA:646 Niemann-Pick disease type C",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/drug/regulatory/645014?name=646&mode=orpha&region=",
          "text": "More details on the regulatory status",
          "type": "regulatory_status"
        }
      ],
      "status": "Tradename",
      "manufacturer": null,
      "indication": "type C\n                                \n\n\n\n\n\n\n            More details on the regulatory status",
      "regions": [
        "US"
      ]
    },
    {
      "name": "YARGESA",
      "substance_url": null,
      "substance_id": null,
      "regulatory_url": "/en/drug/regulatory/642646?name=646&mode=orpha&region=",
      "regulatory_id": "642646",
      "orpha_substance_code": "ORPHA:646",
      "details": [
        "YARGESA(Tradename                        - 15/04/2019)Disease(s) concernedORPHA:646 Niemann-Pick disease type C",
        "YARGESA(Tradename                        - 15/04/2019)",
        "(Tradename                        - 15/04/2019)",
        "Disease(s) concernedORPHA:646 Niemann-Pick disease type C",
        "More details on the regulatory status"
      ],
      "links": [
        {
          "url": "https://www.orpha.net/en/drug/trade_name/484358?name=646&mode=orpha&region=&status=all",
          "text": "YARGESA",
          "type": "trade_name_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/646",
          "text": "ORPHA:646 Niemann-Pick disease type C",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/drug/regulatory/642646?name=646&mode=orpha&region=",
          "text": "More details on the regulatory status",
          "type": "regulatory_status"
        }
      ],
      "status": "Tradename",
      "manufacturer": null,
      "indication": "type C\n                                \n\n\n\n\n\n\n            More details on the regulatory status",
      "regions": [
        "US"
      ]
    },
    {
      "name": "ZAVESCA",
      "substance_url": null,
      "substance_id": null,
      "regulatory_url": "/en/drug/regulatory/131346?name=646&mode=orpha&region=",
      "regulatory_id": "131346",
      "orpha_substance_code": "ORPHA:77259",
      "details": [
        "ZAVESCA(Tradename                        - 21/11/2002)Disease(s) concernedORPHA:646 Niemann-Pick disease type CORPHA:77259 Gaucher disease type 1",
        "ZAVESCA(Tradename                        - 21/11/2002)",
        "(Tradename                        - 21/11/2002)",
        "Disease(s) concernedORPHA:646 Niemann-Pick disease type CORPHA:77259 Gaucher disease type 1",
        "More details on the regulatory status"
      ],
      "links": [
        {
          "url": "https://www.orpha.net/en/drug/trade_name/39961?name=646&mode=orpha&region=&status=all",
          "text": "ZAVESCA",
          "type": "trade_name_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/646",
          "text": "ORPHA:646 Niemann-Pick disease type C",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/77259",
          "text": "ORPHA:77259 Gaucher disease type 1",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/drug/regulatory/131346?name=646&mode=orpha&region=",
          "text": "More details on the regulatory status",
          "type": "regulatory_status"
        }
      ],
      "status": "Tradename",
      "manufacturer": null,
      "indication": "type C\n                                \n\n\n\n\n                                    ORPHA:77259 Gaucher disease type 1\n                                \n\n\n\n\n\n\n            More details on the regulatory status",
      "regions": [
        "US"
      ]
    },
    {
      "name": "Adeno-associated viral vector serotype 9 containing the human NPC1 gene",
      "substance_url": "/en/drug/substance/661195?name=646&mode=orpha&region=&status=all",
      "substance_id": "661195",
      "regulatory_url": "/en/drug/regulatory/661291?name=646&mode=orpha&region=",
      "regulatory_id": "661291",
      "orpha_substance_code": "ORPHA:646",
      "details": [
        "Adeno-associated viral vector serotype 9 containing the human NPC1 gene(Medicinal product                        - 13/10/2023)Disease(s) concernedORPHA:646 Niemann-Pick disease type C",
        "Adeno-associated viral vector serotype 9 containing the human NPC1 gene(Medicinal product                        - 13/10/2023)",
        "(Medicinal product                        - 13/10/2023)",
        "Disease(s) concernedORPHA:646 Niemann-Pick disease type C",
        "More details on the regulatory status"
      ],
      "links": [
        {
          "url": "https://www.orpha.net/en/drug/substance/661195?name=646&mode=orpha&region=&status=all",
          "text": "Adeno-associated viral vector serotype 9 containing the human NPC1 gene",
          "type": "substance_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/646",
          "text": "ORPHA:646 Niemann-Pick disease type C",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/drug/regulatory/661291?name=646&mode=orpha&region=",
          "text": "More details on the regulatory status",
          "type": "regulatory_status"
        }
      ],
      "status": "Medicinal product",
      "manufacturer": null,
      "indication": "type C\n                                \n\n\n\n\n\n\n            More details on the regulatory status",
      "regions": [
        "US"
      ]
    },
    {
      "name": "Ursodeoxycholic acid",
      "substance_url": "/en/drug/substance/25078?name=646&mode=orpha&region=&status=all",
      "substance_id": "25078",
      "regulatory_url": "/en/drug/regulatory/489675?name=646&mode=orpha&region=",
      "regulatory_id": "489675",
      "orpha_substance_code": "ORPHA:77293",
      "details": [
        "Ursodeoxycholic acid(Medicinal product                        - 22/05/2017)Disease(s) concernedORPHA:646 Niemann-Pick disease type CORPHA:77292 Infantile neurovisceral acid sphingomyelinase deficiencyORPHA:77293 Chronic visceral acid sphingomyelinase deficiency",
        "Ursodeoxycholic acid(Medicinal product                        - 22/05/2017)",
        "(Medicinal product                        - 22/05/2017)",
        "Disease(s) concernedORPHA:646 Niemann-Pick disease type CORPHA:77292 Infantile neurovisceral acid sphingomyelinase deficiencyORPHA:77293 Chronic visceral acid sphingomyelinase deficiency",
        "More details on the regulatory status"
      ],
      "links": [
        {
          "url": "https://www.orpha.net/en/drug/substance/25078?name=646&mode=orpha&region=&status=all",
          "text": "Ursodeoxycholic acid",
          "type": "substance_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/646",
          "text": "ORPHA:646 Niemann-Pick disease type C",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/77292",
          "text": "ORPHA:77292 Infantile neurovisceral acid sphingomyelinase deficiency",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/77293",
          "text": "ORPHA:77293 Chronic visceral acid sphingomyelinase deficiency",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/drug/regulatory/489675?name=646&mode=orpha&region=",
          "text": "More details on the regulatory status",
          "type": "regulatory_status"
        }
      ],
      "status": "Medicinal product",
      "manufacturer": null,
      "indication": "type C\n                                \n\n\n\n\n                                    ORPHA:77292 Infantile neurovisceral acid sphingomyelinase deficiency\n                                \n\n\n\n\n                                    ORPHA:77293 Chronic visceral acid sphingomyelinase deficiency\n                                \n\n\n\n\n\n\n            More details on the regulatory status",
      "regions": [
        "US",
        "EU"
      ]
    },
    {
      "name": "Acetylleucine",
      "substance_url": "/en/drug/substance/479413?name=646&mode=orpha&region=&status=all",
      "substance_id": "479413",
      "regulatory_url": "/en/drug/regulatory/487840?name=646&mode=orpha&region=",
      "regulatory_id": "487840",
      "orpha_substance_code": "ORPHA:77293",
      "details": [
        "Acetylleucine(Medicinal product                        - 20/03/2017)Disease(s) concernedORPHA:646 Niemann-Pick disease type CORPHA:77292 Infantile neurovisceral acid sphingomyelinase deficiencyORPHA:77293 Chronic visceral acid sphingomyelinase deficiency",
        "Acetylleucine(Medicinal product                        - 20/03/2017)",
        "(Medicinal product                        - 20/03/2017)",
        "Disease(s) concernedORPHA:646 Niemann-Pick disease type CORPHA:77292 Infantile neurovisceral acid sphingomyelinase deficiencyORPHA:77293 Chronic visceral acid sphingomyelinase deficiency",
        "More details on the regulatory status"
      ],
      "links": [
        {
          "url": "https://www.orpha.net/en/drug/substance/479413?name=646&mode=orpha&region=&status=all",
          "text": "Acetylleucine",
          "type": "substance_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/646",
          "text": "ORPHA:646 Niemann-Pick disease type C",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/77292",
          "text": "ORPHA:77292 Infantile neurovisceral acid sphingomyelinase deficiency",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/77293",
          "text": "ORPHA:77293 Chronic visceral acid sphingomyelinase deficiency",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/drug/regulatory/487840?name=646&mode=orpha&region=",
          "text": "More details on the regulatory status",
          "type": "regulatory_status"
        }
      ],
      "status": "Medicinal product",
      "manufacturer": null,
      "indication": "type C\n                                \n\n\n\n\n                                    ORPHA:77292 Infantile neurovisceral acid sphingomyelinase deficiency\n                                \n\n\n\n\n                                    ORPHA:77293 Chronic visceral acid sphingomyelinase deficiency\n                                \n\n\n\n\n\n\n            More details on the regulatory status",
      "regions": [
        "US",
        "EU"
      ]
    },
    {
      "name": "Arimoclomol citrate",
      "substance_url": "/en/drug/substance/412253?name=646&mode=orpha&region=&status=all",
      "substance_id": "412253",
      "regulatory_url": "/en/drug/regulatory/479979?name=646&mode=orpha&region=",
      "regulatory_id": "479979",
      "orpha_substance_code": "ORPHA:646",
      "details": [
        "Arimoclomol citrate(Medicinal product                        - 19/11/2014)Disease(s) concernedORPHA:646 Niemann-Pick disease type C",
        "Arimoclomol citrate(Medicinal product                        - 19/11/2014)",
        "(Medicinal product                        - 19/11/2014)",
        "Disease(s) concernedORPHA:646 Niemann-Pick disease type C",
        "More details on the regulatory status"
      ],
      "links": [
        {
          "url": "https://www.orpha.net/en/drug/substance/412253?name=646&mode=orpha&region=&status=all",
          "text": "Arimoclomol citrate",
          "type": "substance_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/646",
          "text": "ORPHA:646 Niemann-Pick disease type C",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/drug/regulatory/479979?name=646&mode=orpha&region=",
          "text": "More details on the regulatory status",
          "type": "regulatory_status"
        }
      ],
      "status": "Medicinal product",
      "manufacturer": null,
      "indication": "type C\n                                \n\n\n\n\n\n\n            More details on the regulatory status",
      "regions": [
        "US"
      ]
    },
    {
      "name": "Hydroxy-Propyl-Beta-Cyclodextrin",
      "substance_url": "/en/drug/substance/327849?name=646&mode=orpha&region=&status=all",
      "substance_id": "327849",
      "regulatory_url": "/en/drug/regulatory/332931?name=646&mode=orpha&region=",
      "regulatory_id": "332931",
      "orpha_substance_code": "ORPHA:646",
      "details": [
        "Hydroxy-Propyl-Beta-Cyclodextrin(Medicinal product                        - 26/04/2013)Disease(s) concernedORPHA:646 Niemann-Pick disease type C",
        "Hydroxy-Propyl-Beta-Cyclodextrin(Medicinal product                        - 26/04/2013)",
        "(Medicinal product                        - 26/04/2013)",
        "Disease(s) concernedORPHA:646 Niemann-Pick disease type C",
        "More details on the regulatory status"
      ],
      "links": [
        {
          "url": "https://www.orpha.net/en/drug/substance/327849?name=646&mode=orpha&region=&status=all",
          "text": "Hydroxy-Propyl-Beta-Cyclodextrin",
          "type": "substance_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/646",
          "text": "ORPHA:646 Niemann-Pick disease type C",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/drug/regulatory/332931?name=646&mode=orpha&region=",
          "text": "More details on the regulatory status",
          "type": "regulatory_status"
        }
      ],
      "status": "Medicinal product",
      "manufacturer": null,
      "indication": "type C\n                                \n\n\n\n\n\n\n            More details on the regulatory status",
      "regions": [
        "US"
      ]
    },
    {
      "name": "Hydroxy-Propyl-Beta-Cyclodextrin",
      "substance_url": "/en/drug/substance/327849?name=646&mode=orpha&region=&status=all",
      "substance_id": "327849",
      "regulatory_url": "/en/drug/regulatory/285768?name=646&mode=orpha&region=",
      "regulatory_id": "285768",
      "orpha_substance_code": "ORPHA:646",
      "details": [
        "Hydroxy-Propyl-Beta-Cyclodextrin(Medicinal product                        - 30/08/2011)Disease(s) concernedORPHA:646 Niemann-Pick disease type C",
        "Hydroxy-Propyl-Beta-Cyclodextrin(Medicinal product                        - 30/08/2011)",
        "(Medicinal product                        - 30/08/2011)",
        "Disease(s) concernedORPHA:646 Niemann-Pick disease type C",
        "More details on the regulatory status"
      ],
      "links": [
        {
          "url": "https://www.orpha.net/en/drug/substance/327849?name=646&mode=orpha&region=&status=all",
          "text": "Hydroxy-Propyl-Beta-Cyclodextrin",
          "type": "substance_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/646",
          "text": "ORPHA:646 Niemann-Pick disease type C",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/drug/regulatory/285768?name=646&mode=orpha&region=",
          "text": "More details on the regulatory status",
          "type": "regulatory_status"
        }
      ],
      "status": "Medicinal product",
      "manufacturer": null,
      "indication": "type C\n                                \n\n\n\n\n\n\n            More details on the regulatory status",
      "regions": [
        "US"
      ]
    },
    {
      "name": "Recombinant human heat shock protein 70",
      "substance_url": "/en/drug/substance/323224?name=646&mode=orpha&region=&status=all",
      "substance_id": "323224",
      "regulatory_url": "/en/drug/regulatory/331029?name=646&mode=orpha&region=",
      "regulatory_id": "331029",
      "orpha_substance_code": "ORPHA:646",
      "details": [
        "Recombinant human heat shock protein 70(Medicinal product                        - 12/03/2013)Disease(s) concernedORPHA:646 Niemann-Pick disease type C",
        "Recombinant human heat shock protein 70(Medicinal product                        - 12/03/2013)",
        "(Medicinal product                        - 12/03/2013)",
        "Disease(s) concernedORPHA:646 Niemann-Pick disease type C",
        "More details on the regulatory status"
      ],
      "links": [
        {
          "url": "https://www.orpha.net/en/drug/substance/323224?name=646&mode=orpha&region=&status=all",
          "text": "Recombinant human heat shock protein 70",
          "type": "substance_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/646",
          "text": "ORPHA:646 Niemann-Pick disease type C",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/drug/regulatory/331029?name=646&mode=orpha&region=",
          "text": "More details on the regulatory status",
          "type": "regulatory_status"
        }
      ],
      "status": "Medicinal product",
      "manufacturer": null,
      "indication": "type C\n                                \n\n\n\n\n\n\n            More details on the regulatory status",
      "regions": [
        "US"
      ]
    },
    {
      "name": "Miglustat",
      "substance_url": "/en/drug/substance/65934?name=646&mode=orpha&region=&status=all",
      "substance_id": "65934",
      "regulatory_url": "/en/drug/regulatory/134029?name=646&mode=orpha&region=",
      "regulatory_id": "134029",
      "orpha_substance_code": "ORPHA:646",
      "details": [
        "Miglustat(Medicinal product                        - 16/02/2006)Disease(s) concernedORPHA:646 Niemann-Pick disease type C",
        "Miglustat(Medicinal product                        - 16/02/2006)",
        "(Medicinal product                        - 16/02/2006)",
        "Disease(s) concernedORPHA:646 Niemann-Pick disease type C",
        "More details on the regulatory status"
      ],
      "links": [
        {
          "url": "https://www.orpha.net/en/drug/substance/65934?name=646&mode=orpha&region=&status=all",
          "text": "Miglustat",
          "type": "substance_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/646",
          "text": "ORPHA:646 Niemann-Pick disease type C",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/drug/regulatory/134029?name=646&mode=orpha&region=",
          "text": "More details on the regulatory status",
          "type": "regulatory_status"
        }
      ],
      "status": "Medicinal product",
      "manufacturer": null,
      "indication": "type C\n                                \n\n\n\n\n\n\n            More details on the regulatory status",
      "regions": [
        "US"
      ]
    },
    {
      "name": "AQNEURSA",
      "substance_url": null,
      "substance_id": null,
      "regulatory_url": "/en/drug/regulatory/688270?name=646&mode=orpha&region=",
      "regulatory_id": "688270",
      "orpha_substance_code": "ORPHA:646",
      "details": [
        "AQNEURSA(Tradename                        - 24/09/2024)Disease(s) concernedORPHA:646 Niemann-Pick disease type C",
        "AQNEURSA(Tradename                        - 24/09/2024)",
        "(Tradename                        - 24/09/2024)",
        "Disease(s) concernedORPHA:646 Niemann-Pick disease type C",
        "More details on the regulatory status"
      ],
      "links": [
        {
          "url": "https://www.orpha.net/en/drug/trade_name/688269?name=646&mode=orpha&region=&status=all",
          "text": "AQNEURSA",
          "type": "trade_name_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/646",
          "text": "ORPHA:646 Niemann-Pick disease type C",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/drug/regulatory/688270?name=646&mode=orpha&region=",
          "text": "More details on the regulatory status",
          "type": "regulatory_status"
        }
      ],
      "status": "Tradename",
      "manufacturer": null,
      "indication": "type C\n                                \n\n\n\n\n\n\n            More details on the regulatory status",
      "regions": [
        "US",
        "EU"
      ]
    },
    {
      "name": "MIPLYFFA",
      "substance_url": null,
      "substance_id": null,
      "regulatory_url": "/en/drug/regulatory/688261?name=646&mode=orpha&region=",
      "regulatory_id": "688261",
      "orpha_substance_code": "ORPHA:646",
      "details": [
        "MIPLYFFA(Tradename                        - 20/09/2024)Disease(s) concernedORPHA:646 Niemann-Pick disease type C",
        "MIPLYFFA(Tradename                        - 20/09/2024)",
        "(Tradename                        - 20/09/2024)",
        "Disease(s) concernedORPHA:646 Niemann-Pick disease type C",
        "More details on the regulatory status"
      ],
      "links": [
        {
          "url": "https://www.orpha.net/en/drug/trade_name/688260?name=646&mode=orpha&region=&status=all",
          "text": "MIPLYFFA",
          "type": "trade_name_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/646",
          "text": "ORPHA:646 Niemann-Pick disease type C",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/drug/regulatory/688261?name=646&mode=orpha&region=",
          "text": "More details on the regulatory status",
          "type": "regulatory_status"
        }
      ],
      "status": "Tradename",
      "manufacturer": null,
      "indication": "type C\n                                \n\n\n\n\n\n\n            More details on the regulatory status",
      "regions": [
        "US"
      ]
    },
    {
      "name": "cholesteryl oleate",
      "substance_url": "/en/drug/substance/689507?name=646&mode=orpha&region=&status=all",
      "substance_id": "689507",
      "regulatory_url": "/en/drug/regulatory/689919?name=646&mode=orpha&region=",
      "regulatory_id": "689919",
      "orpha_substance_code": "ORPHA:646",
      "details": [
        "cholesteryl oleate(Medicinal product                        - 28/10/2024)Disease(s) concernedORPHA:646 Niemann-Pick disease type C",
        "cholesteryl oleate(Medicinal product                        - 28/10/2024)",
        "(Medicinal product                        - 28/10/2024)",
        "Disease(s) concernedORPHA:646 Niemann-Pick disease type C",
        "More details on the regulatory status"
      ],
      "links": [
        {
          "url": "https://www.orpha.net/en/drug/substance/689507?name=646&mode=orpha&region=&status=all",
          "text": "cholesteryl oleate",
          "type": "substance_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/646",
          "text": "ORPHA:646 Niemann-Pick disease type C",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/drug/regulatory/689919?name=646&mode=orpha&region=",
          "text": "More details on the regulatory status",
          "type": "regulatory_status"
        }
      ],
      "status": "Medicinal product",
      "manufacturer": null,
      "indication": "type C\n                                \n\n\n\n\n\n\n            More details on the regulatory status",
      "regions": [
        "US"
      ]
    },
    {
      "name": "AAV9-hNPC1 is an Adeno-Associated Virus 9 (AAV9) vector expressing a human cDNA encoding Niemann-Pick C1 (NPC1), under control of the Elongation Factor 1 alpha Short (EF1S) promoter",
      "substance_url": "/en/drug/substance/687146?name=646&mode=orpha&region=&status=all",
      "substance_id": "687146",
      "regulatory_url": "/en/drug/regulatory/687327?name=646&mode=orpha&region=",
      "regulatory_id": "687327",
      "orpha_substance_code": "ORPHA:646",
      "details": [
        "AAV9-hNPC1 is an Adeno-Associated Virus 9 (AAV9) vector expressing a human cDNA encoding Niemann-Pick C1 (NPC1), under control of the Elongation Factor 1 alpha Short (EF1S) promoter(Medicinal product                        - 23/08/2024)Disease(s) concernedORPHA:646 Niemann-Pick disease type C",
        "AAV9-hNPC1 is an Adeno-Associated Virus 9 (AAV9) vector expressing a human cDNA encoding Niemann-Pick C1 (NPC1), under control of the Elongation Factor 1 alpha Short (EF1S) promoter(Medicinal product                        - 23/08/2024)",
        "(Medicinal product                        - 23/08/2024)",
        "Disease(s) concernedORPHA:646 Niemann-Pick disease type C",
        "More details on the regulatory status"
      ],
      "links": [
        {
          "url": "https://www.orpha.net/en/drug/substance/687146?name=646&mode=orpha&region=&status=all",
          "text": "AAV9-hNPC1 is an Adeno-Associated Virus 9 (AAV9) vector expressing a human cDNA encoding Niemann-Pick C1 (NPC1), under control of the Elongation Factor 1 alpha Short (EF1S) promoter",
          "type": "substance_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/646",
          "text": "ORPHA:646 Niemann-Pick disease type C",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/drug/regulatory/687327?name=646&mode=orpha&region=",
          "text": "More details on the regulatory status",
          "type": "regulatory_status"
        }
      ],
      "status": "Medicinal product",
      "manufacturer": null,
      "indication": "type C\n                                \n\n\n\n\n\n\n            More details on the regulatory status",
      "regions": [
        "US"
      ]
    },
    {
      "name": "Adeno-associated viral vector serotype 9 containing the human NPC1 gene",
      "substance_url": "/en/drug/substance/661195?name=646&mode=orpha&region=&status=all",
      "substance_id": "661195",
      "regulatory_url": "/en/drug/regulatory/661644?name=646&mode=orpha&region=",
      "regulatory_id": "661644",
      "orpha_substance_code": "ORPHA:646",
      "details": [
        "Adeno-associated viral vector serotype 9 containing the human NPC1 gene(Medicinal product                        - 06/09/2023)Disease(s) concernedORPHA:646 Niemann-Pick disease type C",
        "Adeno-associated viral vector serotype 9 containing the human NPC1 gene(Medicinal product                        - 06/09/2023)",
        "(Medicinal product                        - 06/09/2023)",
        "Disease(s) concernedORPHA:646 Niemann-Pick disease type C",
        "More details on the regulatory status"
      ],
      "links": [
        {
          "url": "https://www.orpha.net/en/drug/substance/661195?name=646&mode=orpha&region=&status=all",
          "text": "Adeno-associated viral vector serotype 9 containing the human NPC1 gene",
          "type": "substance_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/646",
          "text": "ORPHA:646 Niemann-Pick disease type C",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/drug/regulatory/661644?name=646&mode=orpha&region=",
          "text": "More details on the regulatory status",
          "type": "regulatory_status"
        }
      ],
      "status": "Medicinal product",
      "manufacturer": null,
      "indication": "type C\n                                \n\n\n\n\n\n\n            More details on the regulatory status",
      "regions": [
        "US"
      ]
    },
    {
      "name": "Biphenyl-substituted L-ido configured deoxynojirimycin derivative",
      "substance_url": "/en/drug/substance/641702?name=646&mode=orpha&region=&status=all",
      "substance_id": "641702",
      "regulatory_url": "/en/drug/regulatory/644171?name=646&mode=orpha&region=",
      "regulatory_id": "644171",
      "orpha_substance_code": "ORPHA:646",
      "details": [
        "Biphenyl-substituted L-ido configured deoxynojirimycin derivative(Medicinal product                        - 07/03/2022)Disease(s) concernedORPHA:646 Niemann-Pick disease type C",
        "Biphenyl-substituted L-ido configured deoxynojirimycin derivative(Medicinal product                        - 07/03/2022)",
        "(Medicinal product                        - 07/03/2022)",
        "Disease(s) concernedORPHA:646 Niemann-Pick disease type C",
        "More details on the regulatory status"
      ],
      "links": [
        {
          "url": "https://www.orpha.net/en/drug/substance/641702?name=646&mode=orpha&region=&status=all",
          "text": "Biphenyl-substituted L-ido configured deoxynojirimycin derivative",
          "type": "substance_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/646",
          "text": "ORPHA:646 Niemann-Pick disease type C",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/drug/regulatory/644171?name=646&mode=orpha&region=",
          "text": "More details on the regulatory status",
          "type": "regulatory_status"
        }
      ],
      "status": "Medicinal product",
      "manufacturer": null,
      "indication": "type C\n                                \n\n\n\n\n\n\n            More details on the regulatory status",
      "regions": [
        "US"
      ]
    },
    {
      "name": "N-Acetyl-L-Leucine",
      "substance_url": "/en/drug/substance/591528?name=646&mode=orpha&region=&status=all",
      "substance_id": "591528",
      "regulatory_url": "/en/drug/regulatory/707954?name=646&mode=orpha&region=",
      "regulatory_id": "707954",
      "orpha_substance_code": "ORPHA:646",
      "details": [
        "N-Acetyl-L-Leucine(Medicinal product                        - 08/09/2021)Disease(s) concernedORPHA:646 Niemann-Pick disease type C",
        "N-Acetyl-L-Leucine(Medicinal product                        - 08/09/2021)",
        "(Medicinal product                        - 08/09/2021)",
        "Disease(s) concernedORPHA:646 Niemann-Pick disease type C",
        "More details on the regulatory status"
      ],
      "links": [
        {
          "url": "https://www.orpha.net/en/drug/substance/591528?name=646&mode=orpha&region=&status=all",
          "text": "N-Acetyl-L-Leucine",
          "type": "substance_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/646",
          "text": "ORPHA:646 Niemann-Pick disease type C",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/drug/regulatory/707954?name=646&mode=orpha&region=",
          "text": "More details on the regulatory status",
          "type": "regulatory_status"
        }
      ],
      "status": "Medicinal product",
      "manufacturer": null,
      "indication": "type C\n                                \n\n\n\n\n\n\n            More details on the regulatory status",
      "regions": [
        "US",
        "EU"
      ]
    },
    {
      "name": "Ursodeoxycholic acid",
      "substance_url": "/en/drug/substance/25078?name=646&mode=orpha&region=&status=all",
      "substance_id": "25078",
      "regulatory_url": "/en/drug/regulatory/136885?name=646&mode=orpha&region=",
      "regulatory_id": "136885",
      "orpha_substance_code": "ORPHA:646",
      "details": [
        "Ursodeoxycholic acid(Medicinal product                        - 26/04/2018)Disease(s) concernedORPHA:646 Niemann-Pick disease type C",
        "Ursodeoxycholic acid(Medicinal product                        - 26/04/2018)",
        "(Medicinal product                        - 26/04/2018)",
        "Disease(s) concernedORPHA:646 Niemann-Pick disease type C",
        "More details on the regulatory status"
      ],
      "links": [
        {
          "url": "https://www.orpha.net/en/drug/substance/25078?name=646&mode=orpha&region=&status=all",
          "text": "Ursodeoxycholic acid",
          "type": "substance_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/646",
          "text": "ORPHA:646 Niemann-Pick disease type C",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/drug/regulatory/136885?name=646&mode=orpha&region=",
          "text": "More details on the regulatory status",
          "type": "regulatory_status"
        }
      ],
      "status": "Medicinal product",
      "manufacturer": null,
      "indication": "type C\n                                \n\n\n\n\n\n\n            More details on the regulatory status",
      "regions": [
        "US"
      ]
    },
    {
      "name": "Hydroxy-Propyl-Beta-Cyclodextrin",
      "substance_url": "/en/drug/substance/327849?name=646&mode=orpha&region=&status=all",
      "substance_id": "327849",
      "regulatory_url": "/en/drug/regulatory/400537?name=646&mode=orpha&region=",
      "regulatory_id": "400537",
      "orpha_substance_code": "ORPHA:646",
      "details": [
        "Hydroxy-Propyl-Beta-Cyclodextrin(Medicinal product                        - 18/02/2013)Disease(s) concernedORPHA:646 Niemann-Pick disease type C",
        "Hydroxy-Propyl-Beta-Cyclodextrin(Medicinal product                        - 18/02/2013)",
        "(Medicinal product                        - 18/02/2013)",
        "Disease(s) concernedORPHA:646 Niemann-Pick disease type C",
        "More details on the regulatory status"
      ],
      "links": [
        {
          "url": "https://www.orpha.net/en/drug/substance/327849?name=646&mode=orpha&region=&status=all",
          "text": "Hydroxy-Propyl-Beta-Cyclodextrin",
          "type": "substance_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/646",
          "text": "ORPHA:646 Niemann-Pick disease type C",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/drug/regulatory/400537?name=646&mode=orpha&region=",
          "text": "More details on the regulatory status",
          "type": "regulatory_status"
        }
      ],
      "status": "Medicinal product",
      "manufacturer": null,
      "indication": "type C\n                                \n\n\n\n\n\n\n            More details on the regulatory status",
      "regions": [
        "US"
      ]
    },
    {
      "name": "Hydroxy-Propyl-Beta-Cyclodextrin",
      "substance_url": "/en/drug/substance/327849?name=646&mode=orpha&region=&status=all",
      "substance_id": "327849",
      "regulatory_url": "/en/drug/regulatory/285769?name=646&mode=orpha&region=",
      "regulatory_id": "285769",
      "orpha_substance_code": "ORPHA:646",
      "details": [
        "Hydroxy-Propyl-Beta-Cyclodextrin(Medicinal product                        - 17/05/2010)Disease(s) concernedORPHA:646 Niemann-Pick disease type C",
        "Hydroxy-Propyl-Beta-Cyclodextrin(Medicinal product                        - 17/05/2010)",
        "(Medicinal product                        - 17/05/2010)",
        "Disease(s) concernedORPHA:646 Niemann-Pick disease type C",
        "More details on the regulatory status"
      ],
      "links": [
        {
          "url": "https://www.orpha.net/en/drug/substance/327849?name=646&mode=orpha&region=&status=all",
          "text": "Hydroxy-Propyl-Beta-Cyclodextrin",
          "type": "substance_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/646",
          "text": "ORPHA:646 Niemann-Pick disease type C",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/drug/regulatory/285769?name=646&mode=orpha&region=",
          "text": "More details on the regulatory status",
          "type": "regulatory_status"
        }
      ],
      "status": "Medicinal product",
      "manufacturer": null,
      "indication": "type C\n                                \n\n\n\n\n\n\n            More details on the regulatory status",
      "regions": [
        "US"
      ]
    },
    {
      "name": "PLERIXAFOR ACCORD",
      "substance_url": null,
      "substance_id": null,
      "regulatory_url": "/en/drug/regulatory/642317?name=646&mode=orpha&region=",
      "regulatory_id": "642317",
      "orpha_substance_code": "ORPHA:506219",
      "details": [
        "PLERIXAFOR ACCORD(Tradename                        - 16/12/2022)Disease(s) concernedORPHA:29073 Multiple myelomaORPHA:223735 LymphomaORPHA:506219 Rare disorder potentially indicated for hematopoietic stem cell transplant",
        "PLERIXAFOR ACCORD(Tradename                        - 16/12/2022)",
        "(Tradename                        - 16/12/2022)",
        "Disease(s) concernedORPHA:29073 Multiple myelomaORPHA:223735 LymphomaORPHA:506219 Rare disorder potentially indicated for hematopoietic stem cell transplant",
        "More details on the regulatory status"
      ],
      "links": [
        {
          "url": "https://www.orpha.net/en/drug/trade_name/642316?name=646&mode=orpha&region=&status=all",
          "text": "PLERIXAFOR ACCORD",
          "type": "trade_name_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/29073",
          "text": "ORPHA:29073 Multiple myeloma",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/223735",
          "text": "ORPHA:223735 Lymphoma",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/506219",
          "text": "ORPHA:506219 Rare disorder potentially indicated for hematopoietic stem cell transplant",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/drug/regulatory/642317?name=646&mode=orpha&region=",
          "text": "More details on the regulatory status",
          "type": "regulatory_status"
        }
      ],
      "status": "Tradename",
      "manufacturer": null,
      "indication": "potentially indicated for hematopoietic stem cell transplant\n                                \n\n\n\n\n\n\n            More details on the regulatory status",
      "regions": [
        "US"
      ]
    },
    {
      "name": "Thiotepa Riemser",
      "substance_url": null,
      "substance_id": null,
      "regulatory_url": "/en/drug/regulatory/610636?name=646&mode=orpha&region=",
      "regulatory_id": "610636",
      "orpha_substance_code": "ORPHA:506219",
      "details": [
        "Thiotepa Riemser(Tradename                        - 26/03/2021)Disease(s) concernedORPHA:506219 Rare disorder potentially indicated for hematopoietic stem cell transplant",
        "Thiotepa Riemser(Tradename                        - 26/03/2021)",
        "(Tradename                        - 26/03/2021)",
        "Disease(s) concernedORPHA:506219 Rare disorder potentially indicated for hematopoietic stem cell transplant",
        "More details on the regulatory status"
      ],
      "links": [
        {
          "url": "https://www.orpha.net/en/drug/trade_name/610616?name=646&mode=orpha&region=&status=all",
          "text": "Thiotepa Riemser",
          "type": "trade_name_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/506219",
          "text": "ORPHA:506219 Rare disorder potentially indicated for hematopoietic stem cell transplant",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/drug/regulatory/610636?name=646&mode=orpha&region=",
          "text": "More details on the regulatory status",
          "type": "regulatory_status"
        }
      ],
      "status": "Tradename",
      "manufacturer": null,
      "indication": "potentially indicated for hematopoietic stem cell transplant\n                                \n\n\n\n\n\n\n            More details on the regulatory status",
      "regions": [
        "US"
      ]
    },
    {
      "name": "OFEV",
      "substance_url": null,
      "substance_id": null,
      "regulatory_url": "/en/drug/regulatory/692773?name=646&mode=orpha&region=",
      "regulatory_id": "692773",
      "orpha_substance_code": "ORPHA:182095",
      "details": [
        "OFEV(Tradename                        - 13/07/2020)Disease(s) concernedORPHA:182095 Interstitial lung disease",
        "OFEV(Tradename                        - 13/07/2020)",
        "(Tradename                        - 13/07/2020)",
        "Disease(s) concernedORPHA:182095 Interstitial lung disease",
        "More details on the regulatory status"
      ],
      "links": [
        {
          "url": "https://www.orpha.net/en/drug/trade_name/412134?name=646&mode=orpha&region=&status=all",
          "text": "OFEV",
          "type": "trade_name_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/182095",
          "text": "ORPHA:182095 Interstitial lung disease",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/drug/regulatory/692773?name=646&mode=orpha&region=",
          "text": "More details on the regulatory status",
          "type": "regulatory_status"
        }
      ],
      "status": "Tradename",
      "manufacturer": null,
      "indication": "More details on the regulatory status",
      "regions": [
        "US"
      ]
    },
    {
      "name": "motixafortide",
      "substance_url": "/en/drug/substance/588874?name=646&mode=orpha&region=&status=all",
      "substance_id": "588874",
      "regulatory_url": "/en/drug/regulatory/661036?name=646&mode=orpha&region=",
      "regulatory_id": "661036",
      "orpha_substance_code": "ORPHA:506219",
      "details": [
        "motixafortide(Medicinal product                        - 12/01/2024)Disease(s) concernedORPHA:506219 Rare disorder potentially indicated for hematopoietic stem cell transplant",
        "motixafortide(Medicinal product                        - 12/01/2024)",
        "(Medicinal product                        - 12/01/2024)",
        "Disease(s) concernedORPHA:506219 Rare disorder potentially indicated for hematopoietic stem cell transplant",
        "More details on the regulatory status"
      ],
      "links": [
        {
          "url": "https://www.orpha.net/en/drug/substance/588874?name=646&mode=orpha&region=&status=all",
          "text": "motixafortide",
          "type": "substance_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/506219",
          "text": "ORPHA:506219 Rare disorder potentially indicated for hematopoietic stem cell transplant",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/drug/regulatory/661036?name=646&mode=orpha&region=",
          "text": "More details on the regulatory status",
          "type": "regulatory_status"
        }
      ],
      "status": "Medicinal product",
      "manufacturer": null,
      "indication": "potentially indicated for hematopoietic stem cell transplant\n                                \n\n\n\n\n\n\n            More details on the regulatory status",
      "regions": [
        "US"
      ]
    },
    {
      "name": "haematopoietic stem cells and blood progenitors umbilical cord-derived expanded with (1R, 4R)-N1-(2-benzyl-7-(2-methyl-2H-tetrazol-5-yl)-9H-pyrimido[4,5-b]indol-4-yl)cyclohexane-1,4-diamine dihydrobromide dihydrate",
      "substance_url": "/en/drug/substance/589233?name=646&mode=orpha&region=&status=all",
      "substance_id": "589233",
      "regulatory_url": "/en/drug/regulatory/589234?name=646&mode=orpha&region=",
      "regulatory_id": "589234",
      "orpha_substance_code": "ORPHA:506219",
      "details": [
        "haematopoietic stem cells and blood progenitors umbilical cord-derived expanded with (1R, 4R)-N1-(2-benzyl-7-(2-methyl-2H-tetrazol-5-yl)-9H-pyrimido[4,5-b]indol-4-yl)cyclohexane-1,4-diamine dihydrobromide dihydrate(Medicinal product                        - 20/04/2020)Disease(s) concernedORPHA:506219 Rare disorder potentially indicated for hematopoietic stem cell transplant",
        "haematopoietic stem cells and blood progenitors umbilical cord-derived expanded with (1R, 4R)-N1-(2-benzyl-7-(2-methyl-2H-tetrazol-5-yl)-9H-pyrimido[4,5-b]indol-4-yl)cyclohexane-1,4-diamine dihydrobromide dihydrate(Medicinal product                        - 20/04/2020)",
        "(Medicinal product                        - 20/04/2020)",
        "Disease(s) concernedORPHA:506219 Rare disorder potentially indicated for hematopoietic stem cell transplant",
        "More details on the regulatory status"
      ],
      "links": [
        {
          "url": "https://www.orpha.net/en/drug/substance/589233?name=646&mode=orpha&region=&status=all",
          "text": "haematopoietic stem cells and blood progenitors umbilical cord-derived expanded with (1R, 4R)-N1-(2-benzyl-7-(2-methyl-2H-tetrazol-5-yl)-9H-pyrimido[4,5-b]indol-4-yl)cyclohexane-1,4-diamine dihydrobromide dihydrate",
          "type": "substance_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/506219",
          "text": "ORPHA:506219 Rare disorder potentially indicated for hematopoietic stem cell transplant",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/drug/regulatory/589234?name=646&mode=orpha&region=",
          "text": "More details on the regulatory status",
          "type": "regulatory_status"
        }
      ],
      "status": "Medicinal product",
      "manufacturer": null,
      "indication": "potentially indicated for hematopoietic stem cell transplant\n                                \n\n\n\n\n\n\n            More details on the regulatory status",
      "regions": [
        "US"
      ]
    },
    {
      "name": "Allogeneic multi-virus specific T lymphocytes targeting BK virus, cytomegalovirus, human herpesvirus-6, Epstein Barr virus and adenovirus",
      "substance_url": "/en/drug/substance/589056?name=646&mode=orpha&region=&status=all",
      "substance_id": "589056",
      "regulatory_url": "/en/drug/regulatory/589057?name=646&mode=orpha&region=",
      "regulatory_id": "589057",
      "orpha_substance_code": "ORPHA:506219",
      "details": [
        "Allogeneic multi-virus specific T lymphocytes targeting BK virus, cytomegalovirus, human herpesvirus-6, Epstein Barr virus and adenovirus(Medicinal product                        - 24/03/2020)Disease(s) concernedORPHA:506219 Rare disorder potentially indicated for hematopoietic stem cell transplant",
        "Allogeneic multi-virus specific T lymphocytes targeting BK virus, cytomegalovirus, human herpesvirus-6, Epstein Barr virus and adenovirus(Medicinal product                        - 24/03/2020)",
        "(Medicinal product                        - 24/03/2020)",
        "Disease(s) concernedORPHA:506219 Rare disorder potentially indicated for hematopoietic stem cell transplant",
        "More details on the regulatory status"
      ],
      "links": [
        {
          "url": "https://www.orpha.net/en/drug/substance/589056?name=646&mode=orpha&region=&status=all",
          "text": "Allogeneic multi-virus specific T lymphocytes targeting BK virus, cytomegalovirus, human herpesvirus-6, Epstein Barr virus and adenovirus",
          "type": "substance_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/506219",
          "text": "ORPHA:506219 Rare disorder potentially indicated for hematopoietic stem cell transplant",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/drug/regulatory/589057?name=646&mode=orpha&region=",
          "text": "More details on the regulatory status",
          "type": "regulatory_status"
        }
      ],
      "status": "Medicinal product",
      "manufacturer": null,
      "indication": "potentially indicated for hematopoietic stem cell transplant\n                                \n\n\n\n\n\n\n            More details on the regulatory status",
      "regions": [
        "US"
      ]
    },
    {
      "name": "Burixafor",
      "substance_url": "/en/drug/substance/689505?name=646&mode=orpha&region=&status=all",
      "substance_id": "689505",
      "regulatory_url": "/en/drug/regulatory/689915?name=646&mode=orpha&region=",
      "regulatory_id": "689915",
      "orpha_substance_code": "ORPHA:565779",
      "details": [
        "Burixafor(Medicinal product                        - 22/10/2024)Disease(s) concernedORPHA:565779 Rare disorder potentially indicated for transplant or complication after transplantation",
        "Burixafor(Medicinal product                        - 22/10/2024)",
        "(Medicinal product                        - 22/10/2024)",
        "Disease(s) concernedORPHA:565779 Rare disorder potentially indicated for transplant or complication after transplantation",
        "More details on the regulatory status"
      ],
      "links": [
        {
          "url": "https://www.orpha.net/en/drug/substance/689505?name=646&mode=orpha&region=&status=all",
          "text": "Burixafor",
          "type": "substance_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/565779",
          "text": "ORPHA:565779 Rare disorder potentially indicated for transplant or complication after transplantation",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/drug/regulatory/689915?name=646&mode=orpha&region=",
          "text": "More details on the regulatory status",
          "type": "regulatory_status"
        }
      ],
      "status": "Medicinal product",
      "manufacturer": null,
      "indication": "potentially indicated for transplant or complication after transplantation\n                                \n\n\n\n\n\n\n            More details on the regulatory status",
      "regions": [
        "US"
      ]
    },
    {
      "name": "Besilesomab",
      "substance_url": "/en/drug/substance/571152?name=646&mode=orpha&region=&status=all",
      "substance_id": "571152",
      "regulatory_url": "/en/drug/regulatory/641081?name=646&mode=orpha&region=",
      "regulatory_id": "641081",
      "orpha_substance_code": "ORPHA:506219",
      "details": [
        "Besilesomab(Medicinal product                        - 28/03/2022)Disease(s) concernedORPHA:506219 Rare disorder potentially indicated for hematopoietic stem cell transplant",
        "Besilesomab(Medicinal product                        - 28/03/2022)",
        "(Medicinal product                        - 28/03/2022)",
        "Disease(s) concernedORPHA:506219 Rare disorder potentially indicated for hematopoietic stem cell transplant",
        "More details on the regulatory status"
      ],
      "links": [
        {
          "url": "https://www.orpha.net/en/drug/substance/571152?name=646&mode=orpha&region=&status=all",
          "text": "Besilesomab",
          "type": "substance_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/506219",
          "text": "ORPHA:506219 Rare disorder potentially indicated for hematopoietic stem cell transplant",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/drug/regulatory/641081?name=646&mode=orpha&region=",
          "text": "More details on the regulatory status",
          "type": "regulatory_status"
        }
      ],
      "status": "Medicinal product",
      "manufacturer": null,
      "indication": "potentially indicated for hematopoietic stem cell transplant\n                                \n\n\n\n\n\n\n            More details on the regulatory status",
      "regions": [
        "US"
      ]
    },
    {
      "name": "Besilesomab",
      "substance_url": "/en/drug/substance/571152?name=646&mode=orpha&region=&status=all",
      "substance_id": "571152",
      "regulatory_url": "/en/drug/regulatory/641075?name=646&mode=orpha&region=",
      "regulatory_id": "641075",
      "orpha_substance_code": "ORPHA:506219",
      "details": [
        "Besilesomab(Medicinal product                        - 28/03/2022)Disease(s) concernedORPHA:506219 Rare disorder potentially indicated for hematopoietic stem cell transplant",
        "Besilesomab(Medicinal product                        - 28/03/2022)",
        "(Medicinal product                        - 28/03/2022)",
        "Disease(s) concernedORPHA:506219 Rare disorder potentially indicated for hematopoietic stem cell transplant",
        "More details on the regulatory status"
      ],
      "links": [
        {
          "url": "https://www.orpha.net/en/drug/substance/571152?name=646&mode=orpha&region=&status=all",
          "text": "Besilesomab",
          "type": "substance_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/506219",
          "text": "ORPHA:506219 Rare disorder potentially indicated for hematopoietic stem cell transplant",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/drug/regulatory/641075?name=646&mode=orpha&region=",
          "text": "More details on the regulatory status",
          "type": "regulatory_status"
        }
      ],
      "status": "Medicinal product",
      "manufacturer": null,
      "indication": "potentially indicated for hematopoietic stem cell transplant\n                                \n\n\n\n\n\n\n            More details on the regulatory status",
      "regions": [
        "US"
      ]
    },
    {
      "name": "Treosulfan",
      "substance_url": "/en/drug/substance/90799?name=646&mode=orpha&region=&status=all",
      "substance_id": "90799",
      "regulatory_url": "/en/drug/regulatory/136690?name=646&mode=orpha&region=",
      "regulatory_id": "136690",
      "orpha_substance_code": "ORPHA:565779",
      "details": [
        "Treosulfan(Medicinal product                        - 08/04/2015)Disease(s) concernedORPHA:213500 Rare ovarian cancerORPHA:565779 Rare disorder potentially indicated for transplant or complication after transplantation",
        "Treosulfan(Medicinal product                        - 08/04/2015)",
        "(Medicinal product                        - 08/04/2015)",
        "Disease(s) concernedORPHA:213500 Rare ovarian cancerORPHA:565779 Rare disorder potentially indicated for transplant or complication after transplantation",
        "More details on the regulatory status"
      ],
      "links": [
        {
          "url": "https://www.orpha.net/en/drug/substance/90799?name=646&mode=orpha&region=&status=all",
          "text": "Treosulfan",
          "type": "substance_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/213500",
          "text": "ORPHA:213500 Rare ovarian cancer",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/565779",
          "text": "ORPHA:565779 Rare disorder potentially indicated for transplant or complication after transplantation",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/drug/regulatory/136690?name=646&mode=orpha&region=",
          "text": "More details on the regulatory status",
          "type": "regulatory_status"
        }
      ],
      "status": "Medicinal product",
      "manufacturer": null,
      "indication": "potentially indicated for transplant or complication after transplantation\n                                \n\n\n\n\n\n\n            More details on the regulatory status",
      "regions": [
        "US"
      ]
    },
    {
      "name": "busulfan",
      "substance_url": "/en/drug/substance/46335?name=646&mode=orpha&region=&status=all",
      "substance_id": "46335",
      "regulatory_url": "/en/drug/regulatory/131973?name=646&mode=orpha&region=",
      "regulatory_id": "131973",
      "orpha_substance_code": "ORPHA:565779",
      "details": [
        "busulfan(Medicinal product                        - 21/04/1994)Disease(s) concernedORPHA:565779 Rare disorder potentially indicated for transplant or complication after transplantation",
        "busulfan(Medicinal product                        - 21/04/1994)",
        "(Medicinal product                        - 21/04/1994)",
        "Disease(s) concernedORPHA:565779 Rare disorder potentially indicated for transplant or complication after transplantation",
        "More details on the regulatory status"
      ],
      "links": [
        {
          "url": "https://www.orpha.net/en/drug/substance/46335?name=646&mode=orpha&region=&status=all",
          "text": "busulfan",
          "type": "substance_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/565779",
          "text": "ORPHA:565779 Rare disorder potentially indicated for transplant or complication after transplantation",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/drug/regulatory/131973?name=646&mode=orpha&region=",
          "text": "More details on the regulatory status",
          "type": "regulatory_status"
        }
      ],
      "status": "Medicinal product",
      "manufacturer": null,
      "indication": "potentially indicated for transplant or complication after transplantation\n                                \n\n\n\n\n\n\n            More details on the regulatory status",
      "regions": [
        "US"
      ]
    }
  ],
  "processing_timestamp": "2025-07-07T05:59:58.977486",
  "run_number": 2,
  "total_drugs_found": 32,
  "search_url": "https://www.orpha.net/en/drug?diseaseName=Niemann-Pick+disease+type+C&orphaCode=646&name=646&region=&mode=orpha&status=all",
  "search_params": {
    "diseaseName": "Niemann-Pick disease type C",
    "orphaCode": "646",
    "name": "646",
    "region": "",
    "mode": "orpha",
    "status": "all"
  }
}